Search

Your search keyword '"FINESSI, Monica"' showing total 2 results
Start Over Author "FINESSI, Monica" Database OpenAIRE
2 results on '"FINESSI, Monica"'

1. Imaging medullary thyroid cancer patients with detectable serum markers: state of the art and future perspectives

Author

Julien Hadoux, Désirée Deandreis, Domenico Salvatore, Martin Schlumberger, Carmela Nappi, Monica Finessi, Alberto Cuocolo, Michele Klain, Raffaele Ambrosio, Klain, Michele, Hadoux, Julien, Nappi, Carmela, Finessi, Monica, Ambrosio, Raffaele, Schlumberger, Martin, Cuocolo, Alberto, Deandreis, Désirée, and Salvatore, Domenico

Subjects
medicine.medical_specialty, Medullary cavity, PET/CT, Endocrinology, Diabetes and Metabolism, Disease, Medullary Thyroid Carcinoma, Imaging, Thyroid carcinoma, Endocrinology, Positron Emission Tomography Computed Tomography, medicine, Humans, Prospective Studies, Thyroid Neoplasms, Tumor marker, Ultrasonography, PET-CT, business.industry, Thyroid, Medullary thyroid cancer, medicine.disease, Carcinoma, Neuroendocrine, medicine.anatomical_structure, MTC, Radiology, business, Biomarkers, Serum markers
Abstract

Purpose: Medullary thyroid carcinoma (MTC) originates from thyroid parafollicular C-cells and represents

Published
2021

2. 68Ga-Prostate-Specific Membrane Antigen 11 PET/CT Detects Residual Glioblastoma After Radical Surgery in a Patient With Synchronous Recurrent Prostate Cancer: A Case Report

Author

Michela Zotta, Emanuela Pilati, Daniele Giovanni Nicolotti, Francesco Ceci, Désirée Deandreis, Beatrice Dionisi, Ivan Cerio, Marilena Bellò, Monica Finessi, Pilati, Emanuela, Nicolotti, Daniele Giovanni, Ceci, Francesco, Finessi, Monica, Cerio, Ivan, Dionisi, Beatrice, Zotta, Michela, Bellò, Marilena, and Deandreis, Désirée

Subjects
Male, Neoplasm, Residual, Gallium Radioisotopes, urologic and male genital diseases, Aged, Disease Progression, Edetic Acid, Glioblastoma, Humans, Prostatic Neoplasms, Recurrence, Oligopeptides, Positron Emission Tomography Computed Tomography, 030218 nuclear medicine & medical imaging, 03 medical and health sciences, Prostate cancer, 0302 clinical medicine, pet, medicine, Glutamate carboxypeptidase II, Neoplasm, Radiology, Nuclear Medicine and imaging, Radical surgery, Gallium Isotopes, PET-CT, business.industry, psma: postate cancer, General Medicine, medicine.disease, Transmembrane protein, Residual, 030220 oncology & carcinogenesis, Cancer research, Recurrent prostate cancer, business
Abstract

Prostate-specific membrane antigen (PSMA) is a transmembrane enzyme also known as folate hydrolase 1 highly expressed by prostate cancer (PCa) cells. However, PSMA overexpression by tumor-associated neovasculature of a variety of solid tumors, including glioblastoma (GBM), has also been proven. This clinical case reports about a 67-year-old man with a history of PCa who underwent radical surgery for GBM and performed a Ga-PSMA-11 PET/CT to restage PCa. PET imaging showed PSMA uptake in GBM residual disease after surgery. This finding suggests a possible role of PSMA inhibitors as diagnostic and therapeutic agents in patients affected by GBM.

Published
2020

Catalog

Books, media, physical & digital resources
See catalog results